HSPB1 and lung carcinoma: We also compared anticancer activity between SW15 and RP101, a small molecule HSP27 inhibitor which is under the phase II clinical trial [23] using lung cancer cells xenograft model and found that SW15 showed the anticancer activity in combination with 17-AAG (Supplementary Figure S5).